CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
19 hedge funds and large institutions have $6.49M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
17% less capital invested
Capital invested by funds: $7.84M → $6.49M (-$1.35M)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$265K | |
| 2 | +$191K | |
| 3 | +$54.3K | |
| 4 |
RPG
Risk Paradigm Group
Austin,
Texas
|
+$46.4K |
| 5 |
Citigroup
New York
|
+$24K |
Top Sellers
| 1 | -$1.18M | |
| 2 | -$239K | |
| 3 | -$36.4K | |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
-$10.5K |
| 5 |
BL
BCWM LLC
Overland Park,
Kansas
|
-$7.18K |